- Home
- HOUR vs ALGS Comparison
HOUR vs ALGS Comparison
Compare HOUR & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- ALGS
- Stock Information
- Founded
- HOUR 2015
- ALGS 2018
- Country
- HOUR United States
- ALGS United States
- Employees
- HOUR N/A
- ALGS N/A
- Industry
- HOUR Catalog/Specialty Distribution
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- ALGS Health Care
- Exchange
- HOUR Nasdaq
- ALGS Nasdaq
- Market Cap
- HOUR 43.2M
- ALGS 36.0M
- IPO Year
- HOUR 2022
- ALGS 2020
- Fundamental
- Price
- HOUR $1.29
- ALGS $6.24
- Analyst Decision
- HOUR
- ALGS Strong Buy
- Analyst Count
- HOUR 0
- ALGS 1
- Target Price
- HOUR N/A
- ALGS $70.00
- AVG Volume (30 Days)
- HOUR 24.8K
- ALGS 153.8K
- Earning Date
- HOUR 06-13-2025
- ALGS 05-06-2025
- Dividend Yield
- HOUR N/A
- ALGS N/A
- EPS Growth
- HOUR N/A
- ALGS N/A
- EPS
- HOUR 0.01
- ALGS N/A
- Revenue
- HOUR $139,408,829.00
- ALGS $3,270,000.00
- Revenue This Year
- HOUR N/A
- ALGS N/A
- Revenue Next Year
- HOUR N/A
- ALGS N/A
- P/E Ratio
- HOUR $186.13
- ALGS N/A
- Revenue Growth
- HOUR 2.71
- ALGS N/A
- 52 Week Low
- HOUR $0.83
- ALGS $3.76
- 52 Week High
- HOUR $6.90
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- HOUR 46.39
- ALGS 54.52
- Support Level
- HOUR $1.22
- ALGS $5.47
- Resistance Level
- HOUR $1.34
- ALGS $6.53
- Average True Range (ATR)
- HOUR 0.08
- ALGS 0.50
- MACD
- HOUR 0.00
- ALGS 0.15
- Stochastic Oscillator
- HOUR 26.43
- ALGS 78.72
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.